These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 21151591)
1. Biological functions of the genes in the mammaprint breast cancer profile reflect the hallmarks of cancer. Tian S; Roepman P; Van't Veer LJ; Bernards R; de Snoo F; Glas AM Biomark Insights; 2010 Nov; 5():129-38. PubMed ID: 21151591 [TBL] [Abstract][Full Text] [Related]
2. [Validation and clinical application of MammaPrint® in patients with breast cancer]. Cuadros M; Llanos A Med Clin (Barc); 2011 May; 136(14):627-32. PubMed ID: 20416899 [TBL] [Abstract][Full Text] [Related]
4. Quantitative label-free mass spectrometry using contralateral and adjacent breast tissues reveal differentially expressed proteins and their predicted impacts on pathways and cellular functions in breast cancer. Gomig THB; Cavalli IJ; Souza RLR; Vieira E; Lucena ACR; Batista M; Machado KC; Marchini FK; Marchi FA; Lima RS; de Andrade Urban C; Cavalli LR; Ribeiro EMSF J Proteomics; 2019 May; 199():1-14. PubMed ID: 30772490 [TBL] [Abstract][Full Text] [Related]
5. Performance characteristics of the MammaPrint Delahaye LJ; Wehkamp D; Floore AN; Bernards R; Van't Veer LJ; Glas AM Per Med; 2013 Nov; 10(8):801-811. PubMed ID: 29776281 [TBL] [Abstract][Full Text] [Related]
6. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis. Vastrad B; Vastrad C; Tengli A; Iliger S Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236 [TBL] [Abstract][Full Text] [Related]
7. Osteopontin induces multiple changes in gene expression that reflect the six "hallmarks of cancer" in a model of breast cancer progression. Cook AC; Tuck AB; McCarthy S; Turner JG; Irby RB; Bloom GC; Yeatman TJ; Chambers AF Mol Carcinog; 2005 Aug; 43(4):225-36. PubMed ID: 15864800 [TBL] [Abstract][Full Text] [Related]
8. Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature. Mook S; Knauer M; Bueno-de-Mesquita JM; Retel VP; Wesseling J; Linn SC; Van't Veer LJ; Rutgers EJ Ann Surg Oncol; 2010 May; 17(5):1406-13. PubMed ID: 20094918 [TBL] [Abstract][Full Text] [Related]
9. Comparison of MammaPrint and TargetPrint results with clinical parameters in German patients with early stage breast cancer. Gevensleben H; Göhring UJ; Büttner R; Heukamp LC; Kunz G; Dimpfl T; Jackisch C; Ortmann O; Albert US; Bender R; De Snoo F; Krijgsman O; Glas AM; Ergönenc YH; Vogel C; Dykgers A; Langwieder C; Rees M; Anzeneder T Int J Mol Med; 2010 Dec; 26(6):837-43. PubMed ID: 21042777 [TBL] [Abstract][Full Text] [Related]
10. An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint Makama M; Drukker CA; Rutgers EJT; Slaets L; Cardoso F; Rookus MA; Tryfonidis K; Van't Veer LJ; Schmidt MK Eur J Cancer; 2017 Apr; 75():5-13. PubMed ID: 28214658 [TBL] [Abstract][Full Text] [Related]
11. [Validation and clinical application of MammaPrint Sánchez-Forgach ER; Carpinteyro-Espín U; Alemán-Áviles JA; Sánchez-Basurto C Cir Cir; 2017; 85(4):320-324. PubMed ID: 27979362 [TBL] [Abstract][Full Text] [Related]
12. Identification of Cancer Hallmarks Based on the Gene Co-expression Networks of Seven Cancers. Yu LH; Huang QW; Zhou XH Front Genet; 2019; 10():99. PubMed ID: 30838028 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice. Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data. Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134 [TBL] [Abstract][Full Text] [Related]
15. Prospective Validation of a Genomic Assay in Breast Cancer: The 70-gene MammaPrint Assay and the MINDACT Trial. Audeh W; Blumencranz L; Kling H; Trivedi H; Srkalovic G Acta Med Acad; 2019 Apr; 48(1):18-34. PubMed ID: 31264430 [TBL] [Abstract][Full Text] [Related]
16. MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients. Slodkowska EA; Ross JS Expert Rev Mol Diagn; 2009 Jul; 9(5):417-22. PubMed ID: 19580427 [TBL] [Abstract][Full Text] [Related]
17. Revisiting 'Hallmarks of Cancer' In Sarcomas. Honoki K; Tsujiuchi T; Kishi S; Kuniyasu H J Cancer; 2024; 15(7):1786-1804. PubMed ID: 38434982 [TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis for the identification of key genes and long non-coding RNAs related to bone metastasis in breast cancer. Teng X; Yang T; Huang W; Li W; Zhou L; Wang Z; Feng Y; Zhang J; Yin X; Wang P; Li G; Yu H; Chen Z; Fan D Aging (Albany NY); 2021 Jul; 13(13):17302-17315. PubMed ID: 34226298 [TBL] [Abstract][Full Text] [Related]
19. Intermediate Filaments as Effectors of Cancer Development and Metastasis: A Focus on Keratins, Vimentin, and Nestin. Sharma P; Alsharif S; Fallatah A; Chung BM Cells; 2019 May; 8(5):. PubMed ID: 31126068 [TBL] [Abstract][Full Text] [Related]